Hillsdale Investment Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-296,904
Closed -$6.18M 551
2022
Q2
$6.18M Buy
296,904
+1,100
+0.4% +$20.6K 0.5% 39
2022
Q1
$6.41M Hold
295,804
0.41% 56
2021
Q4
$8.21M Sell
295,804
-86,110
-23% -$2.09M 0.55% 33
2021
Q3
$8.11M Sell
381,914
-23,900
-6% -$448K 0.63% 29
2021
Q2
$6.7M Buy
+405,814
New +$6.2M 0.53% 36
2020
Q2
Sell
-75,800
Closed -$511K 580
2020
Q1
$511K Hold
75,800
0.06% 291
2019
Q4
$881K Buy
+75,800
New +$856K 0.08% 221
2016
Q1
Sell
-28,000
Closed -$459K 492
2015
Q4
$459K Buy
+28,000
New +$445K 0.17% 97

Other funds holding CCRN

Hillsdale Investment Management's CCRN Position: Q3 2022 in Review

Hillsdale Investment Management sold out of Cross Country Healthcare (CCRN) in Q3 2022, closing a stake of 296,904 shares — an estimated $6.18M sold.

Hillsdale Investment Management first reported a position in CCRN in Q4 2015 and held it in 8 quarters. The position peaked at $8.21M in Q4 2021. 203 funds tracked by Wall St. Rank hold CCRN as of Q3 2022.

  • Hillsdale Investment Management reported no remaining Cross Country Healthcare position as of Q3 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 296,904 Cross Country Healthcare shares in Q3 2022, an estimated $6.18M.
  • Hillsdale Investment Management first reported a position in Cross Country Healthcare in Q4 2015 and held it in 8 quarters.
  • Hillsdale Investment Management's Cross Country Healthcare position peaked at $8.21M in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2022.

Based on Hillsdale Investment Management's 13F filing for Q3 2022, filed 10 Nov 2022.